Phlexglobal

What Phlexglobal does

Phlexglobal, founded in 1997 and headquartered in Chesham, United Kingdom, is a technology and services company specializing in electronic Trial Master File (eTMF) management for the global life sciences industry. The company operates as a wholly-owned subsidiary of Cencora, Inc. (formerly AmerisourceBergen), following a January 2022 merger with PharmaLex that expanded its regulatory affairs capabilities. Phlexglobal serves pharmaceutical, biotechnology, medical device, and Contract Research Organization (CRO) customers through a dual offering: a purpose-built cloud-based eTMF software platform (PhlexTMF, with variants including Enterprise, Express, for Viewing, for CROs, and for MedTech) and a vendor-agnostic portfolio of expert services spanning the full TMF lifecycle including heatmaps, quality review, document processing, study owner outsourcing, consulting, M&A support, migrations, training, and Veeva Vault support.

The company's underlying technology stack includes the proprietary PhlexNeuron machine learning framework, trained on tens of millions of TMF documents, which powers AI-assisted document classification achieving 95% accuracy and reducing processing effort by 16%. The platform aligns with the TMF Reference Model standard and integrates NLP for metadata extraction, anomaly detection, and self-improving knowledge retrieval. Phlexglobal operates globally with offices in the UK, US, Poland, Germany, and India, leveraging a team of 150+ TMF professionals under CEO Olivier Teissedre.

The business model combines subscription-based SaaS revenue from the PhlexTMF platform with professional services revenue from its expert services portfolio. The company employs a consultative enterprise field sales motion targeting large and mid-size pharmaceutical, biotech, and medical device companies, with no publicly disclosed pricing. Cumulative scale metrics include 3,500+ studies executed and 20,000,000+ documents processed across the company's 26-year operating history. Notable customer relationships include Regeneron, where Phlexglobal achieved 50% improvement in defined quality KPIs through a centralized TMF processing partnership.

Name

Phlexglobal

Legal name

Phlexglobal Ltd.

Website

https://phlexglobal.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

251–500 employees

Short description

Phlexglobal is a UK-headquartered provider of electronic Trial Master File (eTMF) software and vendor-agnostic TMF services for pharmaceutical, biotech, medical device, and CRO clients. A Cencora subsidiary, it combines a purpose-built cloud platform with proprietary AI (PhlexNeuron) for clinical trial documentation management.

Ownership category

akta.pro rank

Product category

Clinical Trial Document Management Software

NAICS

Custom Computer Programming Services (541511), Computer Systems Design Services (541512)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming Services (7371)

akta.pro primary industry

eTMF & Trial Document Management (HLACAOAF)

akta.pro secondary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Trial Master File software
• Electronic Trial Master File
• Clinical trial document management
• Regulatory Information Management
• TMF quality review services

Headquarters

HQ city

Amersham

HQ country

United Kingdom

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. PhlexTMF Software Platform: SaaS-based electronic Trial Master File software platform providing purpose-built TMF management capabilities. Subscription-based model with cloud deployment.
2. TMF Expert Services: Comprehensive services including heatmaps, quality review, document processing, study owners, consulting services, M&A support, migrations & imports, expert training, and Veeva Vault support. Vendor-agnostic services that can be implemented on any eTMF system.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

Phlexglobal provides a purpose-built electronic Trial Master File (eTMF) software platform (PhlexTMF) and a vendor-agnostic suite of TMF expert services for life sciences companies running clinical trials. The cloud-based PhlexTMF platform is AI-enabled through the PhlexNeuron framework for automated document classification and metadata extraction, while the services portfolio covers heatmaps, quality review, document processing, study owners, consulting, M&A support, migrations, training, and Veeva Vault support. The offering targets pharmaceutical, biotech, medical device companies, and CROs needing inspection-ready TMF management across the clinical trial lifecycle.

Product overview

Phlexglobal offers a dual approach: a purpose-built eTMF software platform (PhlexTMF) and vendor-agnostic expert services. The PhlexTMF platform includes PhlexTMF Enterprise (core comprehensive AI-enabled eTMF), PhlexTMF Express (streamlined version), PhlexTMF for Viewing (long-term archive storage), PhlexTMF for CROs (CRO-specific deployment), and PhlexTMF for MedTech (medical device configuration). The services portfolio covers the full TMF lifecycle including Heatmaps, Quality Review, Document Processing, Study Owners, Consulting Services, M&A Support, Migrations & Imports, Expert Training, and Veeva Vault Support. The company also leverages its proprietary PhlexNeuron AI framework for automated document classification and metadata extraction across its platform. Phlexglobal operates as a global organization with offices in UK, US, Poland, Germany, and India, serving the Life Sciences industry since 1997.

Differentiator

Problem solved

Functional benefit

Brands

• PhlexTMF: Purpose-built eTMF platform - comprehensive, AI-enabled solution for Trial Master File management and control
• PhlexTMF Enterprise
• PhlexTMF Express
• PhlexTMF for Viewing
• PhlexTMF for CROs
• PhlexTMF for MedTech
• PhlexNeuron
• PhlexRIM
• PhlexHealth

Products and services

• PhlexTMF Enterprise Comprehensive, AI-enabled purpose-built eTMF platform designed from the ground up for Trial Master File management, offering powerful and flexible TMF control aligned with the TMF Reference Model. Built for enterprise pharmaceutical, biotech, and CRO customers requiring robust TMF management across the clinical trial lifecycle.
• PhlexTMF Express Streamlined version of the PhlexTMF platform offering core eTMF functionality for organizations seeking essential TMF management capabilities with simpler implementation.
• PhlexTMF for Viewing Purpose-built solution for inspectable and affordable long-term eTMF storage after study closure, addressing the TMF Compliance Gap when CROs return eTMF content in portable formats.
• PhlexTMF for CROs eTMF solution tailored for Contract Research Organizations, enabling CROs to manage sponsor TMF content with appropriate access controls and sponsor oversight capabilities.
• PhlexTMF for MedTech Specialized eTMF configuration for medical device companies to meet device-specific regulatory requirements including EU MDR compliance.
• Heatmaps Service TMF health assessment service providing visual heatmaps to identify quality, completeness, and timeliness gaps for inspection readiness, deliverable on any eTMF system.
• Quality Review Service Expert quality review services to verify document quality, accuracy, and compliance within the Trial Master File.
• Document Processing Service High-quality paper and electronic document processing, remapping, and archival services ensuring completeness, timeliness, and accuracy of TMF documents.
• Study Owners Service Outsourced study owner services providing experienced TMF professionals to manage trial master file responsibilities on behalf of sponsors.
• Consulting Services Expert TMF domain consulting to optimize eTMF technology, people, and processes for TMF health and regulatory compliance.
• M&A Support Service Trial Master File migration and support services for mergers and acquisitions, including study transfers between eTMF systems.
• Migrations & Imports Service Validated migration services for transferring TMF content between systems, including mapping to TMF Reference Model standards and quality control during import.
• Expert Training Service Comprehensive TMF technology and process training programs for study teams and TMF professionals.
• Veeva Vault Support Service Specialized support services for organizations using Veeva Vault eTMF systems, including implementation, migration, and ongoing operational support.

Quantifiable outcome

• 16% reduction in document processing effort with AI-assisted indexing while maintaining quality
• +2 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature7 records

Partnerships

Three partnerships are on record, tiered core and minor.

• RegeneroncoreStrategic or Co-development PartnerPhlexglobal and Regeneron have developed a collaborative model for TMF continuous quality improvement. The partnership evolved from transactional service delivery to genuine strategic partnership focused on shared values of openness, transparency, and collaboration. Phlexglobal provides centralized TMF processing and indexing for Regeneron's clinical trials, with joint development of metrics, heatmaps, and process improvements. The partnership has achieved 50% improvement in quality KPIs and influenced broader organizational practices including cross-functional engagements, onboarding processes, and vendor management procedures.
• TrialbeeminorOthersRick Riegel, Phlexglobal's former CEO, was appointed to Trialbee's Board of Directors. Rick Riegel brings over 30 years of life sciences executive experience including leading Phlexglobal and LIQUENT to successful exits. This represents a personal connection/board appointment rather than a formal company partnership.
• CencoracoreOthersPhlexglobal is a subsidiary of Cencora, Inc. (formerly AmerisourceBergen). The parent company provides corporate infrastructure and support. In January 2022, Phlexglobal merged with PharmaLex (also part of Cencora), expanding capabilities in regulatory affairs and clinical solutions.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• IQVIA: IQVIA provides end-to-end clinical trial services and technology, including eTMF and clinical document management capabilities via its R&D Solutions portfolio. As a CRO with embedded technology, IQVIA competes with Phlexglobal for sponsor TMF budgets at the largest pharmaceutical accounts.
• MasterControl: MasterControl is recognized alongside Phlexglobal as a leading RIM/life sciences compliance vendor. It operates a broader quality and compliance platform that overlaps with TMF/eTMF functionality for regulated life sciences customers, but it is not a pure-play eTMF specialist.
• Oracle Health Sciences (Clinical One): Oracle offers Clinical One and broader clinical trial technology suites that include eTMF and trial management capabilities. Oracle's enterprise scale and unified platform positioning compete with PhlexTMF for large pharma standardization deals.

Direct peers

• ArisGlobal: ArisGlobal competes alongside Phlexglobal in the Regulatory Information Management (RIM) and eTMF markets, offering LifeSphere and regulatory submission solutions. Both companies serve pharma/biotech sponsors with regulatory-driven document management and AI-enabled compliance tooling.
• Veeva Systems: Veeva Vault is the dominant eTMF platform serving pharmaceutical and biotech sponsors; it competes head-to-head with PhlexTMF for sponsor-side eTMF deployments. Phlexglobal even offers dedicated Veeva Vault support services, underscoring the direct competitive overlap in clinical trial document management.
• SureClinical: SureClinical offers a cloud-native eTMF platform purpose-built for life sciences, directly comparable to PhlexTMF. Both target mid-market pharma/biotech sponsors with SaaS-based TMF management and inspection readiness tooling.
• BioClin (formerly eTMF Connect): BioClin provides purpose-built eTMF and TMF operations services to sponsors and CROs, directly competing with PhlexTMF and Phlexglobal's vendor-agnostic services. Both companies focus on TMF document management, inspection readiness, and study owner outsourcing.

Emerging players

• Cencora PharmaLex: PharmaLex is the sister company that merged with Phlexglobal in January 2022 under Cencora. Both operate under Cencora's life sciences services umbrella and now jointly address regulatory affairs and TMF/clinical documentation needs for shared pharmaceutical customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Phlexglobal
• Facebookfacebook.com/phlexglobal
• LinkedInlinkedin.com/company/64731

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Phlexglobal